KNSAKiniksa Pharmaceuticals International, plc
Health Care
Employee-related Liabilities, Current revised up 223.4% for Q3 2025
Employee-related Liabilities, Current·As of Dec 31, 2025
Major restatement$21.4M▲ 223.4%
was$6.6M
Revised up in a 10-Q.
No amendment filed
As reported · Feb 24, 202610-Q · Oct 27, 2026us-gaap:EmployeeRelatedLiabilitiesCurrentVerify against SEC filingsShow
As reported$6.6M
Accepted 2026-02-240001104659-26-019168
Restated$21.4M
Accepted 2026-10-270001104659-26-119186
AccruedExpenses · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time KNSA — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.